Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.16519 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Steven A Muller und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia, Genetic Testing, Heart Rate. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The study was supported by the IMPACT Project from the EU Horizon Pathfinder Program, Dutch Research Council (Open Technology Program; 18485), Horizon 2020 Eur….
Abstract (Originalsprache)
Arrhythmogenic cardiomyopathy (ACM) is a genetically heterogeneous inherited cardiomyopathy with an estimated prevalence of 1:5000–10 000 that predisposes patients to life‐threatening ventricular arrhythmias (VA) and sudden cardiac death (SCD). ACM diagnostic criteria and risk prediction models, particularly for arrhythmogenic right ventricular cardiomyopathy (ARVC), the most common form of ACM, are typically genotype‐agnostic, but numerous studies have established clinically meaningful genotype‐phenotype associations. Early signs of ACM onset differ by genotype indicating the need for genotype‐specific diagnostic criteria and family screening paradigms. Likewise, risk factors for SCD vary by genetic subtype, indicating that genotype‐specific guidelines for management are also warranted. Of particular importance, genotype‐specific therapeutic approaches are being developed. Results from a randomized controlled trial for flecainide use in ARVC patients are currently pending. Research in a plakophilin‐2‐deficient mouse model suggests this antiarrhythmic drug may be particularly useful for patients with likely pathogenic or pathogenic (LP/P) PKP2 variants. Additionally, the first gene therapy clinical trials in ARVC patients harboring LP/P PKP2 variants are currently underway. This review aims to provide clinicians caring for ACM patients with an up‐to‐date overview of the current literature in genotype‐specific natural history of disease and management of ACM patients and describe scientific advances that have led to upcoming clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
- Member of the European Reference Network for Rare, low prevalence and complex diseases of the heart: ERN GUARD-Heart', Amsterdam, The Netherlands.
- Leon H. Charney Division of Cardiology, New York University Grossman School of Medicine, New York, New York, USA.
- Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.
ORCID-Profile: Steven A Muller, Alessio Gasperetti, Moniek G P J Cox, Hugh Calkins
Förderung
- The study was supported by the IMPACT Project from the EU Horizon Pathfinder Program, Dutch Research Council (Open Technology Program; 18485), Horizon 2020 Eur…
Zitieren
APA
Muller, S. A., Bertoli, G., Wang, J., Gasperetti, A., Cox, M. G. P. J., Calkins, H., Riele, A. S. J. M. T., Judge, D. P., Delmar, M., Hauer, R. N. W., Boink, G. J. J., Cerrone, M., Tintelen, J. P. V., & James, C. A. (2025). Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16519
Vancouver
Muller SA, Bertoli G, Wang J, Gasperetti A, Cox MGPJ, Calkins H, et al. Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16519
BibTeX
@article{Muller2025,
author = {Muller, Steven A and Bertoli, Giorgia and Wang, Jianan and Gasperetti, Alessio and Cox, Moniek G P J and Calkins, Hugh and Riele, Anneline S J M Te and Judge, Daniel P and Delmar, Mario and Hauer, Richard N W and Boink, Gerard J J and Cerrone, Marina and Tintelen, J Peter van and James, Cynthia A},
title = {Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.16519}
}
EUVIMED